Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 4 Lung Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Pain 2 Lymphoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Postoperative Hemorrhage 1 Polyposis, Gastric 1 Oropharyngeal Neoplasms 1 Nerve Block 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Musculoskeletal Diseases 1 Multiple Myeloma 1 Mouth Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Hairy Cell 1 Leukemia 1 Leiomyoma 1 Hypotension 1 Hodgkin Disease 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Analgesics, Opioid 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Epinephrine × Clear all

NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡